Financhill
Buy
71

TERN Quote, Financials, Valuation and Earnings

Last price:
$40.16
Seasonality move :
1.42%
Day range:
$30.12 - $45.00
52-week range:
$1.87 - $45.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
12.76x
Volume:
13.5M
Avg. volume:
5M
1-year change:
514.2%
Market cap:
$3.6B
Revenue:
--
EPS (TTM):
-$1.03

Earnings Data

Next earnings date for TERN
Mar 19
2026
Most recent earnings per share
-$0.27
Beat by $0.03
(Nov 10/2025)
Consensus Estimate
-$0.30
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TERN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/19/2026 Q4 -- -- -- -$0.30 --
11/10/2025 Q3 -- -- -$0.27 -$0.30 $0.03
08/05/2025 Q2 -- -- -$0.26 -$0.29 $0.02
05/08/2025 Q1 -- -- -$0.26 -$0.27 $0.01
03/20/2025 Q4 -- -- -$0.24 -$0.30 $0.06
11/12/2024 Q3 -- -- -$0.28 -$0.32 $0.04
08/05/2024 Q2 -- -- -$0.31 -$0.34 $0.03
05/13/2024 Q1 -- -- -$0.30 -$0.35 $0.04
03/14/2024 Q4 -- -- -$0.29 -$0.29 $0.00
11/14/2023 Q3 -- -- -$0.42 -$0.31 -$0.11
08/08/2023 Q2 -- -- -$0.25 -$0.33 $0.08
05/15/2023 Q1 -- -- -$0.31 -- --
03/27/2023 Q4 -- -- -$0.29 -- --
11/09/2022 Q3 -- -- -$0.44 -- --
08/08/2022 Q2 -- -- -$0.55 -- --
05/16/2022 Q1 -- -- -$0.55 -- --
03/03/2022 Q4 -- $1M -$0.56 -- --
11/15/2021 Q3 -- -- -$0.47 -- --
08/16/2021 Q2 -- -- -$0.43 -- --
05/14/2021 Q1 -- -- -$0.53 -- --
12/31/2020 Q4 -- -- $0.03 -- --
09/30/2020 Q3 -- -- -$0.48 -- --
06/30/2020 Q2 -- -- -$0.39 -- --
03/31/2020 Q1 -- -- -$0.36 -- --
12/31/2019 Q4 -- -- -$0.39 -- --

Terns Pharmaceuticals, Inc. Earnings Questions

  • How Much did Terns Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Terns Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Terns Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Terns Pharmaceuticals, Inc. announced earnings per share of -$0.27 which represents a beat of analyst forecast a -$0.30 per share.

  • Is Terns Pharmaceuticals, Inc. Profitable?

    Terns Pharmaceuticals, Inc. reported -$111K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Terns Pharmaceuticals, Inc. EPS Next Year?

    Terns Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.12 per share to -$1.20 per share next year representing a decrease of -1.36%.

  • When is Terns Pharmaceuticals, Inc.'s Earnings Date?

    Terns Pharmaceuticals, Inc.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock